Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

647 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Coexistence of muscle atrophy and high subcutaneous adipose tissue radiodensity predicts poor prognosis in hepatocellular carcinoma.
Ohara M, Suda G, Kohya R, Sasaki T, Yoda T, Yoshida S, Fu Q, Yang Z, Hosoda S, Maehara O, Ohnishi S, Tokuchi Y, Kitagataya T, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Ogawa K, Sakamoto N. Ohara M, et al. Among authors: hosoda s. Front Nutr. 2023 Oct 6;10:1272728. doi: 10.3389/fnut.2023.1272728. eCollection 2023. Front Nutr. 2023. PMID: 37867493 Free PMC article.
Health assessment of rice cultivated and harvested from plasma-irradiated seeds.
Okumura T, Tanaka H, Nakao T, Anan T, Arita R, Shiraki M, Shiraki K, Miyabe T, Yamashita D, Matsuo K, Attri P, Kamataki K, Yamashita N, Itagaki N, Shiratani M, Hosoda S, Tanaka A, Ishibashi Y, Koga K. Okumura T, et al. Among authors: hosoda s. Sci Rep. 2023 Oct 14;13(1):17450. doi: 10.1038/s41598-023-43897-y. Sci Rep. 2023. PMID: 37838753 Free PMC article.
Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma.
Kohya R, Suda G, Ohara M, Sasaki T, Yoda T, Sakurai N, Yoshida S, Fu Q, Yang Z, Hosoda S, Maehara O, Ohnishi S, Tokuchi Y, Kitagataya T, Suzuki K, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Ogawa K, Sakamoto N. Kohya R, et al. Among authors: hosoda s. Cancers (Basel). 2023 Jun 20;15(12):3257. doi: 10.3390/cancers15123257. Cancers (Basel). 2023. PMID: 37370867 Free PMC article.
Recent prevalence and characteristics of patients with hepatitis delta virus in Hokkaido, Japan.
Sasaki T, Suda G, Ohara M, Hosoda S, Kawagishi N, Kohya R, Yoda T, Maehara O, Ohnishi S, Yoshida S, Fu Q, Yang Z, Tokuchi Y, Kitagataya T, Suzuki K, Nakai M, Sho T, Natsuizaka M, Komukai S, Ogawa K, Sakamoto N. Sasaki T, et al. Among authors: hosoda s. Hepatol Res. 2023 Oct;53(10):960-967. doi: 10.1111/hepr.13936. Epub 2023 Jul 3. Hepatol Res. 2023. PMID: 37332115
Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment.
Hosoda S, Suda G, Sho T, Ogawa K, Kimura M, Yang Z, Yoshida S, Kubo A, Tokuchi Y, Kitagataya T, Maehara O, Ohnishi S, Nakamura A, Yamada R, Ohara M, Kawagishi N, Natsuizaka M, Nakai M, Morikawa K, Furuya K, Baba M, Yamamoto Y, Suzuki K, Izumi T, Meguro T, Terashita K, Ito J, Miyagishima T, Sakamoto N. Hosoda S, et al. Liver Cancer. 2022 Oct 31;12(2):156-170. doi: 10.1159/000527759. eCollection 2023 Jun. Liver Cancer. 2022. PMID: 37325489 Free PMC article.
Hepatitis C virus eradication by direct-acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low-density lipoprotein cholesterolemia without an increase in body weight.
Tokuchi Y, Suda G, Kawagishi N, Ohara M, Kohya R, Sasaki T, Yoda T, Maehara O, Ohnishi S, Kubo A, Yoshida S, Fu Q, Yang Z, Hosoda S, Kitagataya T, Suzuki K, Nakai M, Sho T, Natsuizaka M, Ogawa K, Sakamoto N. Tokuchi Y, et al. Among authors: hosoda s. Hepatol Res. 2023 Jul;53(7):595-606. doi: 10.1111/hepr.13899. Epub 2023 Apr 4. Hepatol Res. 2023. PMID: 36945790
647 results